Hyderabad, Nov. 3 -- Nucelion Therapeutics Pvt Ltd, a newly established Hyderabad-based Contract Research, Development, and Manufacturing Organisation (CRDMO) focused on cell and gene therapies, announced its formal launch on Monday.

Nucelion is a wholly owned subsidiary of Bharat Biotech International Ltd.

The CRDMO aims to support global life science innovators with high-quality, scalable process development and manufacturing solutions for advanced therapies, indicated for cancers, autoimmune disorders, and rare genetic disorders, according to a press release issued by Bharat Biotech.

The future of pharmaceutical innovation will be biological, with new modalities expected to drive a large share of growth worldwide. Within this shift,...